Califf Sets Exit At FDA, Ostroff Could Return To Acting Commissioner Post

Former acting commissioner in line for the temporary position again under FDA policy, unless incoming Trump administration designates someone else.

FDA entrance sign 2016

More from Regulation

More from Policy & Regulation